Table 3.
Clinical, biochemical characteristics and anthropometric parameters in control group according to PPARG Pro12Ala polymorphism
| Pro/Ala + Ala/Ala Mean (± SD) | Pro/Pro Mean (± SD) | |
|---|---|---|
| Age (years) | 23 ± 2.3 | 22 ± 2.5 |
| BMI (kg/m2) | 23.12 ± 7.8 | 24.2 ± 8.9 |
| Systolic BP (mmHg) | 125.3 ± 10.3 | 116.2 ± 9.2 |
| Diastolic BP(mmHg) | 76.6 ± 9.2 | 74 ± 11.3 |
| MUAC (cm) | 26.9 ± 5.3 | 26.5 ± 2.4 |
| WC (cm) | 90.1 ± 9.5 | 85.39 ± 7.7 |
| Hip circumference (cm) | 121.59 ± 9.8 | 120.33 ± 8.5 |
| WHR | 0.81 ± 0.07 | 0.86 ± 0.09 |
| Sum SF (mm) | 98.6 ± 11.9 | 99.19 ± 12.4 |
| FBG (mg/dl) | 105.52 ± 5.22 | 96.52 ± 6. 22 |
| FBI (μU/ml) | 10.20 ± 0.75 | 8.20 ± 0.80 |
| HOMA-IR | 2.3 ± .99 | 2.88 ± 1.01 |
| Triglycerides (mg/dl) | 114.41 ± 10.29 | 115.65 ± 11.61 |
| Total cholesterol (mg/dl) | 114.71 ± 11.81 | 119.71 ± 10.45 |
| LDL-C (mg/dl) | 112.61 ± 21.38 | 113.71 ± 25.89 |
BMI: Body mass index; WHR: Waist to hip ratio; (HOMA-IR): Homeostasis Model Insulin Resistance; Sum SF: the sum of skin folds, FBG: fasting blood glucose; FBI: fasting blood insulin, Values are mean (standard deviation).